【レポートの概要（一部）】
1. Report Overview
1.1 Global Pharma Wholesale and Distribution Industry and Market Overview
1.2 Pharma Wholesale and Distribution Industry Structure
1.3 Benefits of This Report
1.4 How This Report Delivers
1.5 Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Pharma Wholesale and Distribution
2.1 The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry
2.1.1 Full-Line Wholesalers (FLWs)
2.1.2 Short-Line Wholesalers (SLWs)
2.2 The Chain of Distribution: Wholesalers vs. Logistic Service Providers
2.2.1 Secondary Wholesalers
2.2.2 Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent
2.2.3 Major Wholesalers: Distribution of a Large Number of Products to Generate High Profits
2.2.4 Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain
2.2.5 Pharmacy Benefit Managers
2.3 Generative Revenue and Profit
2.3.1 Forward Buying to Avoid Price Increases
2.3.2 Fee-for-Service: A Clear Pricing Structure
2.3.2.1 Inventory Management Agreements
2.3.3 Discounts: Incentives for Prompt Payment or Bulk Purchases
2.3.4 Reimbursement and Wholesalers
2.3.5 Clawback: The Recovery of Reimbursement Costs by Governments
2.3.6 Parallel Trade: Different Attitudes in Europe and the US
3. The World Pharmaceutical Wholesale and Distribution Market: 2015-2026
3.1 The World Pharmaceutical Wholesale and Distribution Market in 2015, Restricted by Government Price Reductions and Generic Substitution
3.2 The Pharmaceutical Wholesale and Distribution Industry: World Market Forecast, 2015-2026
3.3 Branded and Generic Drugs: Revenue vs. Profit, 2015-2026
3.3.1 Branded and Generic Drugs: Revenue Generation, 2015
3.3.2 Branded Drugs: Revenue Forecast, 2015-2026
3.3.3 Generic Drugs: Revenue Forecast, 2015-2026
4. Pharmaceutical Wholesale and Distribution Industry: Leading National Markets, 2015-2026
4.1 The Leading National Markets: the US Dominates in 2015
4.2 The Future of the Leading National Markets: Will the US Continue to Dominate the Market?
4.3 The US Pharma Wholesale and Distribution Market
4.3.1 The Budget Control Act and its Effect on the US Wholesale and Distribution Industry
4.3.2 Legislation to Prevent Counterfeit Drugs Can Differ Between States
4.3.3 An Increase in Fee-For-Service Activity
4.3.4 Pharma Wholesale and Distribution Market in the US: Market Forecast, 2015-2026
4.4 The Leading European (EU5) Pharma Wholesale and Distribution Markets
4.4.1 The Difference Between the US and European Markets
4.4.2 State-Funded Healthcare and Reimbursement
4.4.3 EU5: Market Forecast, 2015-2026
4.4.4 Germany: Pharma Wholesale and Distribution Market, 2015
4.4.4.1 Healthcare Reform
4.4.4.2 Germany: Reform of AMNOG Pharmaceutical Rebate Law
4.4.4.3 Germany Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.4.5 France: Pharma Wholesale and Distribution Market, 2015
4.4.5.1 France: Social Security Finance Bill 2015
4.4.5.2 France: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.4.6 Italy: Pharma Wholesale and Distribution Market, 2015
4.4.6.1 Italy: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.4.7 Spain: Pharma Wholesale and Distribution Market, 2015
4.4.7.1 Spain: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.4.8 UK: Pharma Wholesale and Distribution Market, 2015
4.4.8.1 Price Cuts in the UK
4.4.8.2 UK: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.5 Japan: Pharma Wholesale and Distribution Market, 2015
4.5.1 Drug Pricing and Performing Fees in Japan
4.5.2 Japan: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.6 China: Pharma Wholesale and Distribution Market, 2015
4.6.1 China: Leading Pharma Wholesale and Distribution Companies, 2015
4.6.2 China: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.7 Brazil: Pharma and Wholesale Distribution Market, 2015
4.7.1 Drug Price Controls in Brazil
4.7.2 Brazil: Leading Pharma Wholesale and Distribution Companies, 2015
4.7.3 Brazil: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.8 India: Pharma Wholesale and Distribution Market, 2015
4.8.1 India: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.9 Russia: Pharma Wholesale and Distribution Market, 2015
4.9.1 Drug Pricing Controls in Russia
4.9.2 Market Trends in Russia
4.9.3 Russia: Pharma Wholesale and Distribution Market Forecast, 2015-2026
4.10 Conclusion
5. Leading Pharma Wholesalers and Distributors in 2016: Current and Future Performance
5.1 The Leading Pharma Wholesalers and Distribution Companies in 2015
5.2 Revenue vs. Profit
5.3 Leading Pharma Wholesale and Distribution Companies: Grouped Forecasts, 2015-2026
5.4 McKesson: The Oldest and Largest Healthcare Services Company in the US
5.4.1 McKesson: Historical Performance, 2010-2015
5.4.2 Future Strategies: Consummate Acquisitions to Complement Existing Business or Expand Businesses
5.4.3 McKesson: Revenue Forecast, 2015-2026
5.5 Cardinal Health: The World’s Third Largest Pharma Wholesaler
5.5.1 Cardinal Health: Historical Performance, 2010-2015
5.5.2 Will CVS Joint Venture and Acquisitions Stimulate Future Growth?
5.5.3 Cardinal Health: Revenue Forecast, 2015-2026
5.6 AmerisourceBergen: Second Largest Global Pharma Wholesaler and Distributor
5.6.1 AmerisourceBergen: Historical Performance, 2015
5.6.2 Will Contracts with Walgreens and Alliance Boots Drive Future Growth?
5.6.3 AmerisourceBergen: Revenue Forecast, 2015-2026
5.7 Walgreens Boots Alliance: The Largest Drugstore Chain in the US and Global Wholesale and Distribution Network
5.7.1 Walgreens Boots Alliance: Historical Performance, 2011-2015
5.7.2 Acquisitions and Future Strategies of Walgreens Boots Alliance
5.7.3 Walgreens Boots Alliance: Revenue Forecast, 2015-2026
5.8 MEDIPAL HOLDINGS CORPORATION: Japan’s Leading Pharmaceutical Wholesaler
5.8.1 MEDIPAL HOLDINGS CORPORATION: Historical Performance, 2011-2015
5.8.2 Future Strategies of MEDIPAL HOLDINGS CORPORATION: Revised Business Portfolio with Diverse Sources of Earnings
5.8.3 MEDIPAL HOLDINGS CORPORATION: Revenue Forecast, 2015-2026
5.9 Phoenix Group: Biggest European Wholesalers
5.9.1 The PHOENIX Group: Historical Performance, 2011-2015
5.9.2 Future Strategies of the PHOENIX Group: Selective Acquisition
5.9.3 The PHOENIX Group: Revenue Forecast, 2015-2026
5.10 SINOPHARM: The Leading Pharmaceutical Wholesaler and Distributor in China
5.10.1 SINOPHARM: Historical Performance, 2011-2015
5.10.2 Future Strategies of SINOPHARM: Provide Comprehensive Services and Wider Business Coverage
5.10.3 SINOPHARM: Revenue Forecast, 2015-2026
5.11 Alfresa Holdings: Second Largest Pharmaceutical Wholesaler and Distributor in Japan
5.11.1 Alfresa Holdings: Historical Performance, 2011-2015
5.11.2 Future Strategy of Alfresa Holdings: To Focus on Expanding Business Fields and Increasing Footprint
5.11.3 Alfresa Holdings: Revenue Forecast, 2015-2026
5.12 SUZUKEN CO., LTD: The First Nationwide Wholesaler of Japan
5.12.1 SUZUKEN CO. LTD: Historical Performance, 2011-2015
5.12.2 Future Strategies of SUZUKEN CO., LTD: Five Growth Initiatives and Special Focus on Diabetes Field
5.12.3 SUZUKEN CO., LTD: Revenue Forecast, 2015-2026
5.13 Shanghai Pharmaceuticals Holding: China’s Second Largest Wholesaler
5.13.1 Shanghai Pharmaceuticals Holding: Historical Performance, 2011-2015
5.13.2 Future Strategies of Shanghai Pharma: Expansion of Three Leading Regions in China
5.13.3 Shanghai Pharma: Revenue Forecast, 2015-2026
6. Qualitative Analysis of the Pharma Wholesale and Distribution Market
6.1 The Strengths and Weaknesses of the Pharma Wholesale and Distribution Market, 2016
6.1.1 The Insatiable Demand for Drugs: A Recession Proof Industry?
6.1.2 Wholesalers Do More than Deliver Drugs
6.1.2.1 Pre-Wholesaling: More Prevalent in Europe
6.1.2.2 Through Pre-Financing, Full-Line Wholesalers Finance the Entire Medicines Market
6.1.3 Large Companies Dominate the Market
6.1.4 Despite High Revenues, Profit Margins Are Low
6.1.5 Government-Induced Drug Price Pressures Restrict Profits
6.1.6 The Problem of Counterfeit Drugs
6.2 The Opportunities and Threats of the Pharma Wholesale and Distribution Market, 2015-2026
6.2.1 The Demand for Pharmaceuticals is Increasing
6.2.2 The Increasing Use of Specialty Drugs Will Drive Growth
6.2.3 The Increasing Use of Generic Drugs Will Limit Revenue, But Drive Profit Generation
6.2.4 The Promotion of Drug Therapy in the US
6.2.5 Globalisation: The Major National Markets are Dominated by Few Companies
6.2.6 Increased Adoption of the DTP Distribution Model
6.2.6.1 DTP in Europe: The First Place the Scheme Has Taken Hold
6.2.6.2 DTP in the UK Since 1991
6.2.6.3 DTP in Poland: The Second European Country To Adopt the DTP Model
6.2.6.4 Further Expansion of the DTP Model
6.2.7 The Threat of Healthcare Budget Cuts
6.2.7.1 Healthcare Budget Cuts in Germany
6.2.7.2 Healthcare Budget Cuts in France
6.2.7.3 Healthcare Budget Cuts in Italy
6.2.7.4 Healthcare Budget Cuts in Spain
6.2.7.5 Healthcare Budget Cuts in the UK
6.2.8 Do Large Pharmacy Chains Pose a Threat?
6.2.8.1 Case Study: Walmart and the $4 Prescription Scheme
6.2.8.2 Vertical Integration of Wholesalers: A Response to the Threat of Pharmacy Chains
6.2.9 Does the Diversion and Re-Importation of Medicines Pose a Threat to the Industry?
6.2.10 The Threat of Industry Consolidation
6.3 Social, Technological, Economical and Political Factors Influencing the Market, 2015-2026 (STEP Analysis)
6.3.1 Political Factor: The Impact of Recent Regulatory Changes in the EU
6.3.2 Political Factor: Combating Counterfeit Medicines
6.3.2.1 The US and E-Pedigree: Becoming Law in California
6.3.2.2 European Pedigree Legislation
6.3.2.3 Anti-Counterfeiting Strategies in Other Markets: The Chinese Government is Attempting to Address the Challenge
6.3.2.4 Serialisation for Wholesalers: Opportunity or a Challenge?
7. Research Interview
7.1 Interview with Mr Chris Frost, Sales Director of AAH Pharmaceuticals Ltd., (Celesio UK), Coventry
7.1.1 Current Status and Evolution of Pharma Wholesale and Distribution Market, UK
7.1.2 Driving Factors of the Pharma Wholesale and Distribution Market in the UK?
7.1.3 Future of the UK Pharma Wholesale and Distribution Market
7.1.4 Celesio UK Accounted for More than 60% of the Group’s Total Retail Pharmacy Business in 2013
7.1.5 The Outcome of McKesson’s Acquisition of Celesio AG
7.1.6 Prominent Business Segments of Celesio AG in the Future
8. Conclusions
8.1 The Future of the Pharma Wholesale and Distribution Market
8.2 The Leading National Pharma Wholesale and Distribution Markets
8.3 The Leading Companies in the Pharma Wholesale and Distribution Industry
8.4 Trends in the Pharma Wholesale and Distribution Industry
8.4.1 Generics Will Threaten Revenue
8.4.2 Manufacturers Will Deliver More Drugs Directly
8.4.3 There Will Be Greater Demand for Specialty Medicines
8.4.4 Consolidation Will Drive Growth
8.4.5 Anti-Counterfeiting Demands Will Add to Wholesalers’ Costs
【レポート販売概要】
■ タイトル：医薬品卸売・物流の世界市場予測2016-2026■ 英文：Pharma Wholesale and Distribution Market Forecasts 2016-2026
■ 発行日：2016年9月
■ 調査会社：visiongain
■ 商品コード：VGAIN61117
■ 調査対象地域：グローバル
- 企業内教育の世界市場2016-2020About Corporate TrainingCompanies are expanding their businesses worldwide, leading to intense competition in recruitment, training, and retaining talent. Advanced tools and technologies are available in the market to help organizations design and develop training programs for employees irrespective of the location of the delivery center. Technavio’s analysts forecast the global corporate training …
- 風力発電産業向けナセル搭載LIDARシステムの世界市場2017-2021About Nacelle Mounted LIDAR Systems Market for Wind IndustryNacelle LIDAR is used to measure the wind speed and the direction of the wind directly ahead of the turbine. Although it is installed on the nacelle, it can measure the wind without being affected by the turbine. The main purpose of the installing nacelle LIDAR is for integration for turbine control and as a retrofit for independently mea …
- 電動式コントロールバルブ（調節弁）の世界市場About Motorized Control ValvesMotorized control valves are valves that are equipped with actuators or motors. These are used as on/off valves in many of the end-user industries for flow control in various industrial processes. The motor or an actuator designated for valves is connected to a control panel that helps in remote controlling of valves. Technavio’s analysts forecast the global motorized …
- 建築照明の世界市場ABSTRACTAbout Architectural Lighting Architectural lighting is defined as lighting, used to illuminate building structures with architectural elements. They are used for both functional and decorative purpose. The architectural lighting market includes lighting applications for indoor lighting and outdoor lighting. The indoor and outdoor segments are the major drivers for the architectural lightin …
- 放射線治療の世界市場予測（～2023年）“The radiotherapy market is projected to grow at a CAGR of 4.1% during the forecast period”The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1%. Growth in this market is largely driven by factors such as the growing global prevalence of cancer, increasing adoption of radiotherapy in clinical trials, and the increasing number o …
- パッケージ冷凍システムの世界市場2017-2021About Packaged Refrigeration Packaged refrigeration systems are gaining momentum as they provide substantial cost, space, and time advantages. Packaged refrigeration systems of all individual systems in-factory as opposed to filed fitted systems, which are completed on-site, require only electrical and piping services. As the fabrication of these systems can be completed before hand, they can be i …
- 産業用スケール抑制剤の世界市場2016-2020About the Industrial Anti-Scaling Chemicals Market The global industrial anti-scaling chemicals market is driven by the increasing demand from key end-uses including the oil, gas, and mining and water and wastewater treatment industries. The rapid growth of these industries in leading regions such as APAC, Central and South America, and Africa will be a key contributing factor. Anti-scaling chemic …
- ブロー成形機の世界市場2017-2021About Blow Molding Machinery Market Plastic processing machinery is used to create plastic products using pellets, granules, and powdered forms of raw materials, such as resin and crude oil. Industrial plastic processing machinery includes machines, such as IMMs, extruders, BMMs, hollow molders, 3D plastic printers, and thermal forming machines. Plastic processing machinery finds applications in i …
- ICT投資の優先順位：製薬産業部門- 企業のICT投資計画Why was the report written? In order to provide deeper insights into pharmaceutical companies’ ICT investment priorities and strategic objectives. What is the current market landscape and what is changing? Kable’s survey finds that apart from investing in core technologies (such as security, enterprise applications, and IT systems management), many pharmaceutical companies are looking to adopt gre …
- スマートフリート管理の世界市場：交通手段別（道路、海上航空、鉄道）、用途別（追跡、ADAS、最適化、その他）、接続タイプ別（短距離、長距離）The global smart fleet management market was valued at $276.56 billion in 2017, and is projected to reach $537.53 billion by 2025, registering a CAGR of 8.9% from 2018 to 2025. In 2017, Asia-Pacific accounted for the highest share in the global smart fleet management market. Smart fleet solution is a fully integrated system used in automotive to simplify creation of effective maintenance plans. Sm …
- 世界の政府におけるGIS市場（2012-2016）Introduction to the Market A geospatial information system or geographical information system (GIS) is a set of tools that interprets geographical or geospatial data or information. These systems digitize the received geospatial data, process (store, interpret, analyze, and manipulate) the data, and provide the required output. Market Overview The Global GIS market in the Government sector is one …
- Machine-to-Machine (M2M) and RFIDMachine-to-Machine (M2M) communications and Radio Frequency ID (RFID) together represent a means of direct communication between connection hardware and the object that needs monitoring: the information about its status of performance is directly sent to a computer system without the need for human intervention. This makes automation of processes or consumer action possible. The technology that ut …
- 補聴器の世界市場2016-2020：聴覚補正器、植え込み型補聴器About Hearing AidsTechnological advancements have led to the introduction of certain innovative products in the market. Battery-operated conventional devices have been replaced with advanced wireless hearing aid devices. The rise in prevalent cases of hearing loss and the transition in demographics have contributed to the increased use of hearing aids. Technavio’s analysts forecast the global hear …
- 浮体式生産貯蔵積出設備（FPSO）の世界市場予測（～2024年）The floating production storage and offloading market is projected to reach USD 26.0 billion by 2024, recording a CAGR of 5.9% from 2019 to 2024 The floating production storage and offloading market is projected to reach USD 26.0 billion by 2024 from an estimated USD 19.5 billion in 2019, recording a CAGR of 5.9% during the forecast period. Increase in the deep- and ultra-deepwater oil & gas produ …
- 冷凍冷蔵機器用凝縮器の世界市場2017-2021About Refrigeration CondenserCondensers extract heat from the hot refrigerant gas through the condensing medium, which may be air or water. Water and air are chosen as condensing mediums as they are naturally available and can offer a suitable temperature range for condensing refrigerants. Technavio’s analysts forecast the global refrigeration condenser market to grow at a CAGR of 5.68% during the …
